Literature DB >> 10484760

Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies.

L Schlegel, G Sissia, A Frémaux, P Geslin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10484760      PMCID： PMC89427          DOI： 10.1128/AAC.43.8.2099

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

Review 1.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  In-vitro killing activity of combinations of beta-lactam agents with aminoglycosides against penicillin-resistant pneumococci.

Authors:  L Schlegel; G Sissia; A Fremaux; P Geslin
Journal:  J Antimicrob Chemother       Date:  1997-01       Impact factor: 5.790

3.  Failure of pristinamycin treatment in a case of pneumococcal pneumonia.

Authors:  C Burucoa; T Pasdeloup; C Chapon; J L Fauchère; R Robert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-04       Impact factor: 3.267

4.  Streptogramins: an answer to antibiotic resistance in gram-positive bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

5.  Killing kinetics of RP 59500 and pristinamycin against penicillin-resistant pneumococci.

Authors:  V Barakett; D Lesage; F Delisle; G Richard; J C Petit
Journal:  Pathol Biol (Paris)       Date:  1997-05

6.  MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis.

Authors:  B Fantin; R Leclercq; L Garry; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

8.  Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium.

Authors:  F Caron; H S Gold; C B Wennersten; M G Farris; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

9.  Resistance of two strains of Streptococcus pneumoniae to pristinamycin associated with 16-membered macrolides.

Authors:  J P Emond; A Fremaux; A Dublanchet; G Sissia; P Geslin; A Sedalian; G Lionsquy
Journal:  Pathol Biol (Paris)       Date:  1989-09

10.  Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.

Authors:  B Fantin; R Leclercq; Y Merlé; L Saint-Julien; C Veyrat; J Duval; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.